• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤浸润性树突状细胞对肿瘤衍生抗原的呈递效率低下。

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.

作者信息

Stoitzner Patrizia, Green Laura K, Jung Jae Y, Price Kylie M, Atarea Haley, Kivell Bronwyn, Ronchese Franca

机构信息

Malaghan Institute of Medical Research, Wellington, New Zealand.

出版信息

Cancer Immunol Immunother. 2008 Nov;57(11):1665-73. doi: 10.1007/s00262-008-0487-4. Epub 2008 Mar 1.

DOI:10.1007/s00262-008-0487-4
PMID:18311487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11029823/
Abstract

BACKGROUND

Transplantable B16 melanoma is widely used as a tumor model to investigate tumor immunity. We wished to characterize the leukocyte populations infiltrating B16 melanoma tumors, and the functional properties of tumor-infiltrating dendritic cells (TIDC).

MATERIALS AND METHODS

We used the B16 melanoma cell line expressing ovalbumin protein (OVA) to investigate the phenotype and T cell stimulatory capacity of TIDC.

RESULTS

The majority of leukocytes in B16 melanoma were macrophages, which colocalized with TIDCs, B and T cells to the peripheral area of the tumor. Both myeloid and plasmacytoid DC populations were present within tumors. Most of these DCs appeared immature, but about a third expressed a mature phenotype. TIDCs did not present tumor-derived antigen, as they were unable to induce the proliferation of tumor-specific CD4+ and CD8+ T cells in vitro unless in the presence of specific peptides. Some presentation of tumor-derived antigen could be demonstrated in the tumor-draining lymph node using in vivo proliferation assays. However, while proliferation of CD8+ T cells was reproducibly demonstrated, no proliferation of CD4+ T cells was observed.

CONCLUSION

In summary, our data suggest that DCs in tumors have limited antigen-presenting function. Inefficient antigen presentation extends to the tumor-draining lymph node, and may affect the generation of antitumor immune responses.

摘要

背景

可移植的B16黑色素瘤被广泛用作研究肿瘤免疫的肿瘤模型。我们希望对浸润B16黑色素瘤肿瘤的白细胞群体以及肿瘤浸润树突状细胞(TIDC)的功能特性进行表征。

材料与方法

我们使用表达卵清蛋白(OVA)的B16黑色素瘤细胞系来研究TIDC的表型和T细胞刺激能力。

结果

B16黑色素瘤中的大多数白细胞是巨噬细胞,它们与TIDC、B细胞和T细胞共定位于肿瘤的外周区域。肿瘤内同时存在髓样和浆细胞样DC群体。这些DC中的大多数看起来不成熟,但约三分之一表现出成熟表型。TIDC不呈递肿瘤衍生抗原,因为它们在体外无法诱导肿瘤特异性CD4+和CD8+ T细胞增殖,除非存在特定肽段。使用体内增殖试验可在肿瘤引流淋巴结中证明一些肿瘤衍生抗原的呈递。然而,虽然可重复性地证明了CD8+ T细胞的增殖,但未观察到CD4+ T细胞的增殖。

结论

总之,我们的数据表明肿瘤中的DC具有有限的抗原呈递功能。低效的抗原呈递延伸至肿瘤引流淋巴结,并可能影响抗肿瘤免疫反应的产生。

相似文献

1
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.肿瘤浸润性树突状细胞对肿瘤衍生抗原的呈递效率低下。
Cancer Immunol Immunother. 2008 Nov;57(11):1665-73. doi: 10.1007/s00262-008-0487-4. Epub 2008 Mar 1.
2
Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells.真皮和肿瘤浸润树突状细胞的抗原加工与MHC-II呈递
J Immunol. 2009 Mar 1;182(5):2726-37. doi: 10.4049/jimmunol.0803479.
3
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.B16黑色素瘤肿瘤的局部放射治疗增加了肿瘤抗原特异性效应细胞的产生,这些细胞会迁移至肿瘤部位。
J Immunol. 2005 Jun 15;174(12):7516-23. doi: 10.4049/jimmunol.174.12.7516.
4
Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.负载凋亡肿瘤细胞的树突状细胞可诱导针对B16黑色素瘤的长期保护性CD4+和CD8+ T细胞免疫。
J Immunol. 2003 Dec 1;171(11):5940-7. doi: 10.4049/jimmunol.171.11.5940.
5
Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells.黑色素瘤浸润性树突状细胞诱导由T细胞介导的保护性抗肿瘤反应。
Melanoma Res. 2007 Jun;17(3):169-76. doi: 10.1097/CMR.0b013e3281844531.
6
Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cells.无论是否存在 CD4CD25 调节性 T 细胞,鼠类黑色素瘤浸润树突状细胞在抗原呈递功能上均有缺陷。
PLoS One. 2011 Mar 3;6(3):e17515. doi: 10.1371/journal.pone.0017515.
7
Isolation of immune cells from primary tumors.从原发性肿瘤中分离免疫细胞。
J Vis Exp. 2012 Jun 16(64):e3952. doi: 10.3791/3952.
8
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.肿瘤抗原的加工和呈递严重依赖于树突状细胞的类型以及抗原递呈的方式。
Blood. 2005 Mar 15;105(6):2465-72. doi: 10.1182/blood-2004-08-3105. Epub 2004 Nov 16.
9
Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.在免疫激活剂进行成功的肿瘤免疫治疗期间,单核细胞衍生的树突状细胞的数量增加。
J Immunol. 2013 Aug 15;191(4):1984-92. doi: 10.4049/jimmunol.1301135. Epub 2013 Jul 15.
10
Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy.肿瘤浸润树突状细胞表现出肿瘤抗原交叉呈递功能缺陷,但可被化疗逆转。
Eur J Immunol. 2015 Jan;45(1):49-59. doi: 10.1002/eji.201444722. Epub 2014 Dec 15.

引用本文的文献

1
Natural killer cells: the immune frontline against circulating tumor cells.自然杀伤细胞:抵御循环肿瘤细胞的免疫前线。
J Exp Clin Cancer Res. 2025 Apr 10;44(1):118. doi: 10.1186/s13046-025-03375-x.
2
Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth.从主要组织相容性复合体II类分子中去除恒定链肽存在缺陷会抑制肿瘤抗原呈递并促进肿瘤生长。
Cell Rep. 2025 Jan 28;44(1):115150. doi: 10.1016/j.celrep.2024.115150. Epub 2025 Jan 2.
3
Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better.用光动力疗法和纳米颗粒增强癌症免疫疗法:使肿瘤微环境更“热”以让免疫疗法效果更佳。
Front Immunol. 2024 Apr 5;15:1375767. doi: 10.3389/fimmu.2024.1375767. eCollection 2024.
4
The Killer's Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer.《杀手的网络:癌症中炎症、表观遗传学和营养之间的相互关联》
Int J Mol Sci. 2024 Feb 27;25(5):2750. doi: 10.3390/ijms25052750.
5
Tailoring therapeutics via a systematic beneficial elements comparison between photosynthetic bacteria-derived OMVs and extruded nanovesicles.通过对光合细菌衍生的外膜囊泡和挤压纳米囊泡之间的系统有益元素比较来定制疗法。
Bioact Mater. 2024 Feb 26;36:48-61. doi: 10.1016/j.bioactmat.2024.02.025. eCollection 2024 Jun.
6
Targeting Epigenetic Mechanisms: A Boon for Cancer Immunotherapy.靶向表观遗传机制:癌症免疫治疗的福音
Biomedicines. 2023 Jan 9;11(1):169. doi: 10.3390/biomedicines11010169.
7
CD8 T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.在癌症中,CD8 T 细胞的激活包括淋巴结中的初始激活阶段,随后在肿瘤内进行效应细胞分化。
Immunity. 2023 Jan 10;56(1):107-124.e5. doi: 10.1016/j.immuni.2022.12.002. Epub 2022 Dec 28.
8
Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process.长链非编码 RNA 在黑色素瘤中的调控及其在转移过程中的功能作用。
Cells. 2022 Feb 7;11(3):577. doi: 10.3390/cells11030577.
9
The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy.抗原加工与呈递在癌症中的作用及免疫检查点抑制剂免疫疗法的疗效
Cancers (Basel). 2021 Jan 4;13(1):134. doi: 10.3390/cancers13010134.
10
Overcoming Immune Evasion in Melanoma.克服黑色素瘤的免疫逃逸。
Int J Mol Sci. 2020 Nov 26;21(23):8984. doi: 10.3390/ijms21238984.

本文引用的文献

1
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.抗原识别改变是癌症中CD8 + T细胞耐受的一种机制。
Nat Med. 2007 Jul;13(7):828-35. doi: 10.1038/nm1609. Epub 2007 Jul 1.
2
Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process.淋巴外肿瘤通过T细胞交叉耐受过程使引流淋巴结易于受到侵袭。
Cancer Res. 2007 May 15;67(10):5009-16. doi: 10.1158/0008-5472.CAN-06-4494.
3
Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis.黑色素瘤衍生的神经节苷脂会损害人表皮朗格汉斯细胞的迁移和抗原呈递功能,并诱导其凋亡。
Int Immunol. 2006 Jun;18(6):879-86. doi: 10.1093/intimm/dxl024. Epub 2006 May 4.
4
Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection.肿瘤浸润性树突状细胞是强大的抗原呈递细胞,能够激活T细胞并介导肿瘤排斥反应。
J Immunol. 2006 Jan 1;176(1):61-7. doi: 10.4049/jimmunol.176.1.61.
5
Dendritic cell dysfunction in cancer: a mechanism for immunosuppression.癌症中的树突状细胞功能障碍:一种免疫抑制机制。
Immunol Cell Biol. 2005 Oct;83(5):451-61. doi: 10.1111/j.1440-1711.2005.01371.x.
6
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.B16黑色素瘤肿瘤的局部放射治疗增加了肿瘤抗原特异性效应细胞的产生,这些细胞会迁移至肿瘤部位。
J Immunol. 2005 Jun 15;174(12):7516-23. doi: 10.4049/jimmunol.174.12.7516.
7
Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.交叉呈递肿瘤衍生抗原的树突状细胞的激活使CD8 + 细胞毒性T淋巴细胞能够根除肿瘤。
J Immunol. 2004 Dec 1;173(11):6753-9. doi: 10.4049/jimmunol.173.11.6753.
8
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.卵巢癌中调节性T细胞的特异性募集促进免疫特权并预示生存率降低。
Nat Med. 2004 Sep;10(9):942-9. doi: 10.1038/nm1093. Epub 2004 Aug 22.
9
Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.成熟的DC-Lamp+树突状细胞在肿瘤部位的选择性积聚与黑色素瘤中有效的T细胞介导的抗肿瘤反应及转移扩散的控制相关。
Cancer Res. 2004 Mar 15;64(6):2192-8. doi: 10.1158/0008-5472.can-03-2969.
10
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody.利用CpG免疫刺激寡核苷酸和抗白细胞介素10受体抗体逆转肿瘤诱导的树突状细胞麻痹
J Exp Med. 2002 Aug 19;196(4):541-9. doi: 10.1084/jem.20020732.